Unveiling the Hidden Epidemic: Vulval Leiomyoma, Misdiagnosis, and Healthcare Realities in the Indian Context

Dr. Shilpi Singh

Unveiling the Hidden Epidemic: Vulval Leiomyoma, Misdiagnosis, and Healthcare Realities in the Indian Context

Author(s)	Dr. Shilpi Singh
Country	India
Abstract	Background: Leiomyomas are benign, smooth muscle neoplasms most frequently associated with the myometrium of the uterus. However, their occurrence in extrauterine locations, particularly the vulva, is an exceptionally rare clinical phenomenon. Due to overlapping anatomical and clinical presentations, vulval leiomyomas are frequently and systematically misdiagnosed as Bartholin’s cysts or abscesses, leading to delayed surgical intervention and prolonged patient distress. Objective: This comprehensive article aims to analyze the biological characteristics, diagnostic challenges, and sociocultural factors surrounding vulval leiomyoma, with a specific and deep focus on the Indian healthcare ecosystem. The objective is to bridge the gap between global epidemiological data and the localized realities of Indian women, highlighting systemic vulnerabilities in rural and urban healthcare settings. Methodology: A structured analytical framework was employed to synthesize data from recent peer-reviewed case reports, epidemiological studies, and gynecological literature. The analysis incorporates a critical review of literature from 2008 to 2026, prioritizing recent findings and filtering for cases emphasizing diagnostic dilemmas, histopathological confirmations, and culturally specific healthcare-seeking behaviors in India. Key Findings: 1. Clinical Mimicry: Over 80% of initially documented vulval leiomyomas are misdiagnosed preoperatively as Bartholin cysts due to shared symptomatology, such as painless or mildly uncomfortable solitary masses (He et al., 2023). 2. Diagnostic Deficits: In resource-limited Indian settings, reliance on mere physical examination without adjunct imaging (like transperineal ultrasonography) exacerbates misdiagnosis rates. 3. Sociocultural Barriers: A pervasive "culture of silence" regarding genital health in India, coupled with rural-urban healthcare disparities, significantly delays the average time to clinical presentation. 4. Treatment Efficacy: Complete surgical excision with clear margins remains the gold standard, yielding excellent prognoses and minimal recurrence rates when paired with accurate histopathology (Anurag et al., 2023). Conclusions and Recommendations: Accurate preoperative differentiation between Bartholin cysts and vulval leiomyomas requires heightened clinical suspicion and greater integration of point-of-care ultrasound in primary healthcare settings. Policymakers must focus on destigmatizing genital morbidities and equipping primary health centers (PHCs) with the necessary diagnostic infrastructure to ensure timely, definitive care for Indian women.
Keywords	Vulval Leiomyoma, Bartholin Cyst Misdiagnosis, Indian Healthcare, Gynecological Neoplasms, Smooth Muscle Tumors, Women's Health Policy.
Field	Medical / Pharmacy
Published In	Volume 17, Issue 4, October-December 2026
Published On	2026-10-05

View / Download PDF File

About IJSAT Fees & Payment Current Issue Publication Archive	Submit Research Paper Track Submission Status Publication Guidelines Publication Ethics	Join as a Reviewer Editors & Reviewers Get Reviewer Membership Certi.	Website/Journal Policies Usage Policy Content Policies Privacy Policy

Contact Us	Message on WhatsApp	+91-9687-182-185	editor@ijsat.org

International Journal on Science and Technology

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Unveiling the Hidden Epidemic: Vulval Leiomyoma, Misdiagnosis, and Healthcare Realities in the Indian Context

Share this